newsfilter
← Latest News
GlobeNewswire·

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock

CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or the "Company") (NASDAQ:CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting